ReviewCureus2024
Proton Radiation Therapy for Head and Neck Cancers.
Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Head and neck (HnN) cancers are among the most common cancers in the world. Proton therapy (PT) is one of the latest advancements in the treatment modalities of cancers. Proton therapy is specifically used to treat HnN cancer patients due to its less toxic effects on the surrounding critical structures. Keeping in view the opportunities for further advancements, there is a lot of literature covering PT in HnN cancer patients. However, few compiled studies are not enough to compare the toxicities, overall survival (OS), local control (LC), and quality of life (QoL) of PT with that of intensity-modulated radiation therapy (IMRT). The objective of this review is to compile and summarize the literature available on the toxicities, OS, LC, and QoL in HnN cancer patients post PT. We have gathered and summarized the literature found under the keyword "proton therapy for head and neck cancers". Proton therapy is a preferable option over IMRT because it isolates tumors of the HnN, reduces exposure of healthy cells to radiation, and allows accurate tumor scanning using the pencil beam technique. In view of this article, we can say that PT is a preferable mode of radiotherapy for HnN cancer patients in view of its accuracy and lower incidents of acute and late toxicities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.